Combined treatment with thymosin alpha 1 and interferon enhances NK activity in immunosuppressed tumor bearing mice.
Pica
F
F
Department of Experimental Medicine and Biochemical Sciences, II University of Rome. Via Orazio Raimondo 00173 Rome, Italy.
Mastino
A
A
Grelli
S
S
Jezzi
T
T
Favalli
C
C
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D003520:Cyclophosphamide / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D007165:Immunosuppression Therapy; D007372:Interferons / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D000077596:Thymalfasin; D013947:Thymosin / Q000031:analogs & derivatives* / Q000494:pharmacology
D000276:Adjuvants, Immunologic; D013947:Thymosin; D003520:Cyclophosphamide; D007372:Interferons; D000077596:Thymalfasin